Free Trial

agilon health (NYSE:AGL) Shares Down 7.5% - Here's What Happened

agilon health logo with Medical background
Remove Ads

agilon health, inc. (NYSE:AGL - Get Free Report) was down 7.5% on Friday . The stock traded as low as $3.38 and last traded at $3.27. Approximately 1,670,998 shares changed hands during trading, a decline of 63% from the average daily volume of 4,544,696 shares. The stock had previously closed at $3.53.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Barclays lowered their price objective on agilon health from $5.00 to $2.00 and set an "underweight" rating for the company in a research note on Monday, November 11th. JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a research note on Monday, November 11th. TD Cowen cut their price objective on shares of agilon health from $6.00 to $2.00 and set a "hold" rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus raised their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. Finally, Sanford C. Bernstein upped their price target on shares of agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a report on Wednesday, January 15th. Two research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, agilon health currently has a consensus rating of "Hold" and an average price target of $3.95.

Get Our Latest Stock Report on agilon health

agilon health Price Performance

The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a fifty day simple moving average of $3.14 and a 200 day simple moving average of $2.94. The company has a market capitalization of $1.54 billion, a PE ratio of -3.98 and a beta of 0.67.

Remove Ads

Insider Activity

In other agilon health news, Director Karen Mcloughlin bought 25,000 shares of the company's stock in a transaction on Friday, December 13th. The shares were bought at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the acquisition, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 3.20% of the company's stock.

Institutional Trading of agilon health

A number of hedge funds have recently bought and sold shares of the stock. Los Angeles Capital Management LLC bought a new stake in agilon health during the third quarter valued at about $513,000. Aigen Investment Management LP acquired a new stake in shares of agilon health during the third quarter worth $79,000. Simplify Asset Management Inc. increased its position in shares of agilon health by 67.5% in the 3rd quarter. Simplify Asset Management Inc. now owns 168,696 shares of the company's stock valued at $663,000 after acquiring an additional 67,968 shares during the period. Intech Investment Management LLC purchased a new stake in agilon health during the 3rd quarter valued at about $228,000. Finally, Citigroup Inc. increased its holdings in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads